Not-interventional health care project “RA-Express” to implement an efficient screening system for early arthritis

Not-interventional health care project “RA-Express” to implement an efficient screening system for early arthritis - RA Express

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011510

Enrollment

216

Registered

2017-03-02

Start date

2015-01-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L93 L95 M05 M06 M07 M08 M13 M32 M35 M45 M60

Interventions

Group 1: Patients with joint symptoms (no longer than 12 month) get appointment after telephone screening and are seen by physician. If there is a rheumatic disease diagnosed the patient will get a ne

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Prescreening (by phone, online, consultation hours without appointment) •Disease duration from four weeks to maximum 12 months •At least one tender and swollen joint for more than four weeks •No trauma or infection as cause of disorder •No rheumatic diagnostic by other physician (e.g. family doctor, orthopaedist) Requirement for the evaluation of the screened patients: Signed agreement to scientific data collection, data storage and data evaluation.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The aim of this study is to evaluate efficiency of different screening strategies in patients with early arthritis	—

Secondary

Measure	Time frame
Secondary endpoints •frequency of other inflammatory rheumatic diseases with involvement of joint symptoms •number of screened patients diagnosed by physician •number of screened patients diagnosed by health professional assistance using structured screening path •number of patients using a) online questionnaire on our website b) appointment after questioning by phone c) consultation hour without appointment •evaluation of the accuracy of the diagnosis with and without using POCT rheumachec®/ MCV-test kits and CRP-test kits •comparison between supposed diagnosis and final diagnosis •collecting duration between first contact and a) supposed diagnosis b) final diagnosis c) therapy start •collecting duration between first a) supposed diagnosis b) final diagnosis c) therapy start with and without using POCT rheumachec®/ MCV-test kits and CRP-test kits •evaluation of process costs	—

Measure

Time frame

Secondary endpoints •frequency of other inflammatory rheumatic diseases with involvement of joint symptoms •number of screened patients diagnosed by physician •number of screened patients diagnosed by health professional assistance using structured screening path •number of patients using a) online questionnaire on our website b) appointment after questioning by phone c) consultation hour without appointment •evaluation of the accuracy of the diagnosis with and without using POCT rheumachec®/ MCV-test kits and CRP-test kits •comparison between supposed diagnosis and final diagnosis •collecting duration between first contact and a) supposed diagnosis b) final diagnosis c) therapy start •collecting duration between first a) supposed diagnosis b) final diagnosis c) therapy start with and without using POCT rheumachec®/ MCV-test kits and CRP-test kits •evaluation of process costs

—

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026